Ilaya International Group S.l.

What Ilaya International Group S.l. does

Ilaya International Group S.l. is a Spanish-domiciled private medical services holding company that operates a multifunctional clinic in Kiev, Ukraine, founded in 2012 by physicians and scientists to deliver innovative stem-cell medicine. The business is organized into two principal service lines: ilaya Stem Cell Treatments, which offers proprietary therapies including the claimed world-exclusive manufacturing of therapeutic-dose neural fate directed stem cells and unique anaerobic cell cultivation, targeting anti-aging, arthritis, cirrhosis, type 2 diabetes, and plastic surgery support; and ilaya Fertility Clinic (founded 2011), which provides IVF, surrogacy in Ukraine and the Czech Republic, PGD with gender selection, egg/sperm donation, and gestational carrier services. Both divisions share an owned Cryobank facility with EU storage protocols and individual cell identity/biosafety passports for all stem cell products.

The company operates as a direct-to-consumer medical tourism provider, acquiring international patients through multilingual websites (English, Chinese, Spanish, German, French), free 15-minute Skype consultations, WeChat and Telegram messaging, and a network of international offices including sales/marketing presence in New York and San Francisco plus a (currently temporarily closed) Spanish office and a European consultation office. Each patient is assigned a personal manager and offered individualized payment plans; revenue is generated primarily through one-time procedure fees across the treatment catalog and recurring cryobank storage subscriptions. Reported scale includes 30,000+ cumulative patients over 15 years and hundreds of intended parents served through the fertility program. Operational credentials include Ukrainian government licensing for stem-cell-based treatments, ISO 9001 certification, and a 2019 Forbes recognition as one of the '20 Most Innovative Companies in Ukraine'.

Name

Ilaya International Group S.l.

Legal name

Ilaya International Group S.l.

Website

https://ilaya.com

Company type

Private

Founded year

2012

Operating status

Operating

Headcount range

11–50 employees

Short description

Ilaya International Group S.l. is a private medical tourism company operating a Kiev-based clinic offering proprietary stem cell therapies (including neural crest stem cells) and fertility services (IVF and surrogacy in Ukraine and Czech Republic) to international patients, supported by US sales offices and an in-house cryobank.

Ownership category

akta.pro rank

Product category

Stem Cell Therapy and Fertility Services

NAICS

All Other Outpatient Care Centers (621498), Other Ambulatory Health Care Services (6219)

SIC

Services-Health Services (8000), Services-Specialty Outpatient Facilities, Nec (8093)

akta.pro primary industry

Cell Therapy Clinical Services & Treatment Centers (apheresis, administration, monitoring) (HLAAABAJ)

akta.pro secondary industries

Stem Cell Therapies (MSC/iPSC/HSC-derived) (HLAAABAE), Cell Therapy Manufacturing Services (GMP, autologous/allogeneic) (HLAAAKAC)

Keywords

• Stem cell therapy
• Fertility treatments
• In vitro fertilization
• Surrogacy services
• Medical tourism

Headquarters

HQ city

Valencia

HQ country

Spain

HQ region

Europe

Offices4 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Medical Treatment Services: Direct revenue from providing stem cell treatments, IVF procedures, surrogacy services, and other medical procedures to patients. Services include anti-aging treatments, arthritis, cirrhosis, type 2 diabetes treatments, and plastic surgery combined with stem cells.
2. Cryobank Storage Services: Revenue from storing bio-materials (embryos, stem cells, other biological materials) for patients on a long-term basis using their own cryobank facility.
3. Fertility Services: Revenue from IVF, surrogacy programs (Ukraine and Czech Republic), egg donation, sperm donation, preimplantation genetic diagnosis (PGD), and gestational carrier services.

Pricing tiers

Go-to-market motion1 record

Distribution channels5 records

Marketing channels6 records

Core offering

Ilaya International Group operates a multifunctional medical clinic founded in 2012 by physicians and scientists in Ukraine, delivering proprietary stem cell therapies (anti-aging, arthritis, cirrhosis, type 2 diabetes, plastic surgery adjuncts) and integrated fertility services including IVF, surrogacy in Ukraine and the Czech Republic, preimplantation genetic diagnosis (PGD), and donor gamete programs. The company manufactures therapeutic doses of neural crest stem cells in its own laboratory, runs an EU-protocol cryobank, and serves international patients through its Kiev clinic and consultation offices.

Product overview

Ilaya International Group S.l. operates as an integrated medical services platform comprising two main divisions: the ilaya Stem Cell Treatments division (cells.ilaya.com) offering proprietary stem cell therapies using neural crest stem cells, adult stem cells, and anaerobic cell cultivation; and the ilaya Fertility Clinic (ivf.ilaya.com) providing comprehensive assisted reproduction services including IVF, surrogacy, PGD, and donor programs. Both divisions share core infrastructure including an owned Cryobank facility. The company was founded in 2012 by physicians and scientists in Ukraine and positions itself at the forefront of innovative stem cell medicine.

Differentiator

Problem solved

Functional benefit

Brands

• ilaya fertility clinic: Fertility and surrogacy services including IVF, PGD, egg/sperm donation, and gestational carrier programs
• ilaya stem cell treatments

Quantifiable outcome

• 30,000+ patients helped to return to a healthy life
• +2 more outcomes

Named customers5 records

Segments4 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Five partnerships are on record, tiered minor.

• AldgateminorOthersPartner company listed in the 'Our partners' section of ilaya's website. No specific details provided about the nature of the partnership.
• AmbisafeminorOthersPartner company listed in the 'Our partners' section of ilaya's website. No specific details provided about the nature of the partnership.
• AvicenaminorOthersPartner company listed in the 'Our partners' section of ilaya's website. No specific details provided about the nature of the partnership.
• LelekaminorOthersPartner company listed in the 'Our partners' section of ilaya's website. No specific details provided about the nature of the partnership.
• Smart-cellminorOthersPartner company listed in the 'Our partners' section of ilaya's website. No specific details provided about the nature of the partnership.

Scale indicators5 records

Recent moves8 records

Expansion highlights6 records

Direct peers

• BioTexCom: Ukraine-based fertility and surrogacy clinic operating in the same favorable legal environment as ilaya. Closest direct competitor for international intended parents across surrogacy, IVF, and donor services.
• Circle Surrogacy: International surrogacy agency serving intended parents across multiple jurisdictions. Comparable in surrogacy positioning and intended-parent customer demographic, though operates primarily in US surrogacy markets.
• Celltex Therapeutics: US-based adult stem cell therapy provider with international patient pipeline. Comparable in adult stem cell technology, indication breadth, and DTC medical tourism approach.
• Swiss Medica: International stem cell therapy medical tourism provider offering adult stem cell treatments for chronic disease and anti-aging — directly comparable business model, patient funnel, and indication mix to ilaya.
• Beike Biotech: China-based stem cell therapy provider with a large international patient base. Comparable in adult stem cell therapies, cross-border patient acquisition, and regenerative medicine positioning.
• StemGenex: US adult stem cell clinic in California providing autologous stem cell therapies for chronic conditions. Directly comparable service portfolio and direct-to-patient marketing model.
• EmCell: Ukraine-based stem cell therapy clinic operating since 1994, focused on fetal stem cell treatments. Comparable in geography, regulatory positioning, and patient demographic to ilaya's stem cell division.

Emerging players

• Cryo-Cell International: US-based cord blood and stem cell banking company with subscription revenue model. Comparable in cryobank storage operations, though focused on newborn cord blood rather than therapeutic-dose adult stem cells.

Broad incumbents

• IntegraMed America: US fertility clinic network and practice management platform serving IVF patients at scale. Comparable in fertility services scope but operates in regulated US market rather than medical tourism model.
• Boston IVF: One of the largest US fertility clinic networks, offering comprehensive IVF, PGD, and donor services. Comparable fertility service portfolio at significant scale within regulated US market.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/channel/UC4SZvgnUV5OON5ZpNBeTF9g
• LinkedInlinkedin.com/company/ilaya-international-group-s-l

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Ilaya International Group S.l.